Pfizer Animal health rebrands a number of equine vaccines
Pfizer Animal Health’s Duvaxyn and Artervac equine vaccines have been rebranded as part of the pharmaceutical company’s range of Equip equine vaccines.
Equine herpes virus (vaccine Duvaxyn EHV 1,4 has been rebranded Equip EHV 1,4; equine rotavirus vaccine Duvaxyn R has been rebranded Equip Rotavirus, the West Nile Virus vaccine Duvaxyn WNV has been rebranded Equip WNV and equine arteritis vaccine Artervac has been rebranded Equip Artervac.
These products join Pfizer’s flu and tetanus vaccines Equip F, Equip FT and Equip T.
Ben Lacey, Pfizer’s equine business unit manager said: “This move demonstrates our commitment to the equine industry as we strive to become the equine veterinarian’s company of choice for products and services.”
Stay in touch with all the news in the run-up to and throughout the major shows and events during 2026 and beyond with a Horse & Hound subscription. Subscribe today for all you need to know ahead of these major events, plus online reports on the action as it happens from our expert team of reporters and in-depth analysis in our special commemorative magazines. Have a subscription already? Set up your unlimited website access now
Never miss out on the latest happenings in the equestrian world
A self-confessed newshound, farmer’s daughter and journalist of many years' experience, Charlotte worked on regional papers before joining H&H in 2007. A regular rider, she visited Ireland in 2010 to investigate the fate of Irish horses through the recession, to much acclaim, and reported from the FEI General Assembly in Rio de Janeiro in 2011. She left Horse & Hound in March 2013.